Devaux B, Chassoux F, Guenot M, Haegelen C, Bartolomei F, Rougier A, Bourgeois M, Colnat-Coulbois S, Bulteau C, Sol J-C, Kherli P, Geffredo S, Reyns N, Vinchon M, Proust F, Masnou P, Dupont S, Chabardes S, Coubes P
Service de neurochirurgie, centre hospitalier Sainte-Anne, 1, rue Cabanis, 75674 Paris cedex 14, France.
Neurochirurgie. 2008 May;54(3):453-65. doi: 10.1016/j.neuchi.2008.02.041. Epub 2008 May 7.
We report here the results of the first survey on epilepsy surgery activity in France. Data from a questionnaire sent to 17 centers practicing epilepsy surgery were analyzed. All centers responded; however, all items were not completely documented. Over 50 years, more than 5000 patients have been operated on for drug-resistant epilepsy and more than 3000 patients underwent some invasive monitoring, most often SEEG. Currently, nearly 400 patients (including more than 100 children) are operated on yearly for epilepsy in France. Over a study period varying among centers (from two to 20 years; mean, 9.5 years), results from more than 2000 patients including one-third children were analyzed. Important differences between adults and children, respectively, were observed in terms of location (temporal: 72% versus 4.3%; frontal: 12% versus 28%; central: 2% versus 11%), etiology (hippocampal sclerosis: 41% versus 2%; tumors 20% versus 61%); and procedures (cortectomy: 50% versus 23%; lesionectomy: 8% versus 59%), although overall results were identical (seizure-free rates following temporal lobe surgery: 80.6% versus 79%; following extratemporal surgery: 65.9% versus 65%). In adults, the best results were observed following temporomesial (TM) resection associated with hippocampal sclerosis or other lesions (class I: 83% and 79%, respectively), temporal neocortical (TNC) lesional (82%), while resections for cryptogenic temporal resections were followed by 69% (TM) and 63% (TNC) class I outcome. Extratemporal lesional resections were associated with 71% class I outcome and cryptogenic 43%. In children, the best results were obtained in tumor-associated epilepsy regardless of location (class I: 80%). A surgical complication occurred in 8% after resective surgery - with only 2.5% permanent morbidity - and 4.3% after invasive monitoring (mostly hemorrhagic). Overall results obtained by epilepsy surgery centers were in the higher range of those reported in the literature, along with a low rate of major surgical complications. Growing interest for epilepsy surgery is clearly demonstrated in this survey and supports further development to better satisfy the population's needs, particularly children. Activity should be further evaluated, while existing epilepsy surgery centers as well as healthcare networks should be expanded.
我们在此报告法国首次癫痫手术活动调查的结果。对发送给17个开展癫痫手术中心的调查问卷数据进行了分析。所有中心均有回复;然而,并非所有项目都有完整记录。50多年来,超过5000例患者接受了耐药性癫痫手术,超过3000例患者接受了某种侵入性监测,最常见的是立体定向脑电图(SEEG)。目前,法国每年有近400例患者(包括100多名儿童)接受癫痫手术。在各中心不同的研究时间段(从2年到20年;平均9.5年)内,对2000多名患者(其中三分之一为儿童)的结果进行了分析。在位置方面(颞叶:72%对4.3%;额叶:12%对28%;中央区:2%对11%)、病因(海马硬化:41%对2%;肿瘤:20%对61%)以及手术方式(皮质切除术:50%对23%;病灶切除术:8%对59%)方面,分别观察到成人和儿童之间存在重要差异,尽管总体结果相同(颞叶手术后无癫痫发作率:80.6%对79%;颞叶外手术后:65.9%对65%)。在成人中,与海马硬化或其他病变相关的颞叶内侧(TM)切除术后效果最佳(I级:分别为83%和79%),颞叶新皮质(TNC)病灶切除术后为82%,而隐源性颞叶切除术的I级结果在TM切除术后为69%,TNC切除术后为63%。颞叶外病灶切除术的I级结果为71%,隐源性为43%。在儿童中,无论位置如何,与肿瘤相关的癫痫手术效果最佳(I级:80%)。切除性手术后8%发生手术并发症——永久性致残率仅为2.5%,侵入性监测后为4.3%(主要为出血)。癫痫手术中心获得的总体结果处于文献报道的较高水平,且主要手术并发症发生率较低。本次调查清楚地表明对癫痫手术的兴趣日益浓厚,这支持进一步发展以更好地满足民众需求,尤其是儿童的需求。应进一步评估手术活动,同时应扩大现有的癫痫手术中心以及医疗保健网络。